William Rizzo
Clinical Genetics (M.D.) · Omaha, NENPI 1780635839
Payments from drug & device makers
Across 118 payments — averaging $1440.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$85K
- Takeda Pharmaceuticals U.S.A., Inc.$64K
- Sanofi US Services Inc.$11K
- Mirum Pharmaceuticals, Inc.$4K
- Ultragenyx Pharmaceutical Inc.$3K
- Amgen$2K
- plus $677 from 8 others
What the payments were for
- Consulting fees$5,90058%
- Speaking & faculty fees$1,77518%
- Travel & lodging$8428%
- Food & beverage$1,54715%
- Education$561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 48 | $85,487 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $64,483 |
| Sanofi US Services Inc. | 12 | $10,575 |
| Mirum Pharmaceuticals, Inc. | 6 | $3,848 |
| Ultragenyx Pharmaceutical Inc. | 5 | $3,416 |
| Amgen | 5 | $1,504 |
| Sanofi | 6 | $275 |
| Amicus Therapeutics, Inc. | 8 | $157 |
| Shire North American Group Inc | 3 | $58 |
| Travere Therapeutics, Inc. | 5 | $48 |
| PTC Therapeutics, Inc. | 1 | $48 |
| Recordati_rare_diseases_inc. | 1 | $34 |
| UCB, Inc. | 1 | $32 |
| Intrabio Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in Nebraskato place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Omaha
- Richard LutzOmaha$496K
- Craig BakerOmaha$945
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.